Oncternal Therapeutics, Inc. (ONCT) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 4 Buy, 3 Hold.
The consensus price target is $28.00, representing an upside of 5217.1% from the current price $0.53.
ONCT Stock — 12-Month Price Forecast
$28.00
▲ +5,217.13% Upside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Oncternal Therapeutics, Inc., the price target is $28.00.
The average price target represents a +5,217.13% change from the last price of $0.53.
ONCT Analyst Ratings
Buy
Based on 7 analysts giving stock ratings to Oncternal Therapeutics, Inc. in the past 3 months
